In summary, our study found that ASB16-AS1 is down-regulated in adrenocortical carcinoma and it inhibits adrenocortical carcinoma cell cycle progression and proliferation in vitro and in vivo animal experiments. This evidence concerns the gene ASB16 and adrenal cortex carcinoma.